p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment

Regina Hecker, Ralf Amstutz, Marco Wachtel, Dagmar Walter, Felix Niggli, Beat W. Schäfer

Oncogene · 2010 · 31 citations · 23 references

Concepts

References

23